• OPEN AN ACCOUNT
Indian Indices
Sensex
71,418.60 -1,220.10
( -1.68%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,456.95 -84.74
(-0.80%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

DMCC Speciality Chemicals Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
506405
INE505A01010
99.3202881
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DMCC
22.13
884.74
EPS(TTM)
Face Value()
Div & Yield %
16.03
10
0.7
 

Sanofi India jumps after Nippon India MF adds stake
Jun 15,2026
According to exchange data, Nippon India Mutual Fund purchased 2.64 lakh shares, or 1.15% equity, of Sanofi India at Rs 3,150 per share through a bulk deal on 12 June 2026.

The shares were sold by HDFC Life Insurance Company, which offloaded 2.75 lakh shares, or 1.19% equity, at the same price.

As of the March 2026 quarter, Nippon India Small Cap Fund held an aggregate 3.79% stake in Sanofi India, while HDFC Life Insurance Company's Shareholders Solvency Margin Account owned 1.47% of the pharmaceutical company.

Sanofi India is engaged in the manufacture and marketing of pharmaceutical products and vaccines. On a standalone basis, Sanofi India's net profit declined 14.14% to Rs 102.60 crore while net sales declined 11.87% to Rs 472.30 crore in Q4 March 2026 over Q4 March 2025.